Therefore, in order to study the NOX4 activator, p22phox as with NOX4, can assist in the level of mROS in thyroid cancer cells upon hypoxia, p22phox knockout in TPC-1 cells was prepared mediated by CRISPR/Cas9 system. This evidence concerns the gene CYBA and thyroid gland carcinoma.